Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Ruozi

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Pharmaceutics|November 6, 2019
Nanomedicine Against Aβ Aggregation by β-Sheet Breaker Peptide Delivery: In Vitro EvidenceFrancesca Pederzoli, Barbara Ruozi, Jason Duskey, et al.
Pharmaceutics|January 23, 2020
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept StudyGina P Hoyos-Ceballos, Barbara Ruozi, Ilaria Ottonelli, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|January 13, 2018
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc deliveryAntonietta Vilella, Daniela Belletti, Ann Katrin Sauer, et al.
Cells|May 13, 2023
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord InjuryMarzia Moretti, Riccardo Caraffi, Luca Lorenzini, et al.
Current Research in Toxicology|December 9, 2024
Bridging the gap between toxicity and carcinogenicity of mineral fibres by connecting the fibre parameters to the key characteristics of carcinogens: A comprehensive model inspiring asbestos-induced cancer prevention strategiesAlessandro F Gualtieri, Erika Ferrari, Luca Rigamonti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 31, 2025
Corrigendum to 'Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease' J Control Release. 2021 Feb 10;330:587-598Giulia Birolini, Marta Valenza, Ilaria Ottonelli, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 7, 2021
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's diseaseGiulia Birolini, Marta Valenza, Ilaria Ottonelli, et al.
International Journal of Pharmaceutics|September 17, 2022
Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy modelAlessia Romeo, Angela Bonaccorso, Claudia Carbone, et al.
Advances in Neurobiology|July 22, 2023
Nanowired Delivery of Curcumin Attenuates Methamphetamine Neurotoxicity and Elevates Levels of Dopamine and Brain-Derived Neurotrophic FactorIlaria Ottonelli, Aruna Sharma, Barbara Ruozi, et al.
EMBO Molecular Medicine|November 22, 2015
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease miceMarta Valenza, Jane Y Chen, Eleonora Di Paolo, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Pharmaceutics|November 6, 2019
Nanomedicine Against Aβ Aggregation by β-Sheet Breaker Peptide Delivery: In Vitro EvidenceFrancesca Pederzoli, Barbara Ruozi, Jason Duskey, et al.
Pharmaceutics|January 23, 2020
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept StudyGina P Hoyos-Ceballos, Barbara Ruozi, Ilaria Ottonelli, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|January 13, 2018
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc deliveryAntonietta Vilella, Daniela Belletti, Ann Katrin Sauer, et al.
Cells|May 13, 2023
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord InjuryMarzia Moretti, Riccardo Caraffi, Luca Lorenzini, et al.
Current Research in Toxicology|December 9, 2024
Bridging the gap between toxicity and carcinogenicity of mineral fibres by connecting the fibre parameters to the key characteristics of carcinogens: A comprehensive model inspiring asbestos-induced cancer prevention strategiesAlessandro F Gualtieri, Erika Ferrari, Luca Rigamonti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 31, 2025
Corrigendum to 'Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease' J Control Release. 2021 Feb 10;330:587-598Giulia Birolini, Marta Valenza, Ilaria Ottonelli, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 7, 2021
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's diseaseGiulia Birolini, Marta Valenza, Ilaria Ottonelli, et al.
International Journal of Pharmaceutics|September 17, 2022
Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy modelAlessia Romeo, Angela Bonaccorso, Claudia Carbone, et al.
Advances in Neurobiology|July 22, 2023
Nanowired Delivery of Curcumin Attenuates Methamphetamine Neurotoxicity and Elevates Levels of Dopamine and Brain-Derived Neurotrophic FactorIlaria Ottonelli, Aruna Sharma, Barbara Ruozi, et al.
EMBO Molecular Medicine|November 22, 2015
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease miceMarta Valenza, Jane Y Chen, Eleonora Di Paolo, et al.
Pageof 11